Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Sequencing Reagents Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Sequencing Reagents Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Sequencing Reagents Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Sequencing Reagents Market: Technology Movement Analysis, USD Million, 2023 & 2030
4.3. Sanger Sequencing
4.3.1. Sanger Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Next-Generation Sequencing
4.4.1. Next-Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Third Generation Sequencing
4.5.1. Third Generation Sequencing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Sequencing Reagents Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Sequencing Reagents Market: Type Movement Analysis, USD Million, 2023 & 2030
5.3. Library Kits
5.3.1. Library Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Template Kits
5.4.1. Template Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Control Kits
5.5.1. Control Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Sequencing Kits
5.6.1. Sequencing Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Sequencing Reagents Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Sequencing Reagents Market: Application Movement Analysis, USD Million, 2023 & 2030
6.3. Oncology
6.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Reproductive Health
6.4.1. Reproductive Health Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Clinical Investigation
6.5.1. Clinical Investigation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Agrigenomics and forensics
6.6.1. Agrigenomics and Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Consumer Genomics
6.7.1. Consumer Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Sequencing Reagents Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Sequencing Reagents Market: End Use Movement Analysis, USD Million, 2023 & 2030
7.3. Academic Research
7.3.1. Academic Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Clinical Research
7.4.1. Clinical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Hospital and Clinics
7.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Pharmaceutical & biotechnology Companies
7.6.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Sequencing Reagents Market: Regional Estimates & Trend Analysis
8.1. Sequencing Reagents Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
8.2.1. North America Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.6. South Korea
8.4.6.1. South Korea Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Sequencing Reagent Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Sequencing Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Illumina, Inc.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. QIAGEN
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. BGI
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. PacBio
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. F. Hoffmann-La Roche Ltd
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Oxford Nanopore Technologies plc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Agilent Technologies, Inc.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Standard BioTools (Fluidigm Corporation)
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Integrated DNA Technologies, Inc. (ArcherDX, Inc.)
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Takara Bio Inc.
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. Meridian (Bioline)
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/ Strategic Initiatives